Anwita Biosciences Inc.
PrivateLast Round
Series B
Jun 28, 2021
Est. Valuation
$50M
Total Funding Raised
$28.5M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Anwita Biosciences Inc. is a clinical-stage biotechnology company that develops next-generation cancer immunotherapies, including its lead candidate AWT020.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Anwita Biosciences Inc. Comparables
Compare Anwita Biosciences Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cugene Inc. | 83% | |
| Bright Peak Therapeutics | 81% | |
| Aulos Bioscience | 80% | |
Anwita Biosciences Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 28, 2021 | ||||
| Series A | Jun 24, 2019 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors increased 65% MoM, reaching 2.8K.
- Mar 3, 2026
Monthly visitors increased 33% MoM.
Anwita Biosciences Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Anwita Biosciences Inc.'s valuation, stock price, and market status.